Details view | IP Australia | Trade Mark Search

Additional fields:
Address History and Publication details Endorsements as at 10 November 2018 Opposition details

Trade mark 2597212

IR number	1882134
Words	PADAGIS NALOXONE
Image
Image description	CHEVRON DIVIDES GREEK CROSS
Status	protected: Registered/protected
Priority date	06 May 2025 (Convention)
Classes	5, 10, 20, 35, 44
Kind	Figurative

Dates
Renewal due	26 May 2035
Registration advertised / published	28 Jan 2026
Entered on Register	28 Jan 2026
Acceptance advertised / published	20 Nov 2025
Acceptance	20 Nov 2025
IR notification	23 Oct 2025
Filing	26 May 2025
Registered from	26 May 2025

Owner	Address for service
PADAGIS US LLC 1251 LINCOLN ROAD ALLEGAN MI 49010 UNITED STATES OF AMERICA	Madderns Pty Ltd GPO Box 2752 Adelaide, SA, 5001 AUSTRALIA

IR Contact
Wolff, Bregman and Goller Technology Park Malha, Bldg 98 9695101 Jerusalem ISRAEL

IR Contact

Wolff, Bregman and Goller

Goods & Services

Class 5: Medicinal preparations used as a narcotic antagonist; pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations.

Class 10: Medical kits consisting of intranasal drug delivery devices, spray pump devices for nasal delivery, and training kits with devices for nasal delivery, sold empty.

Class 20: Medicine cabinets.

Class 35: Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose; online pharmacy services.

Class 44: Medical and health information services; providing information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips for patients, medical professionals, and pharmacists, via a website; providing pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists, via a website.

Endorsements	The mark consists of the words "Padagis" above "Naloxone and +. It is a condition of protection that, in use, the cross device contained within the trade mark will be rendered in colours other than red on a white or silver background, or white or silver on a red background.;It is a condition of registration that, in use, the cross device contained within the trade mark will be rendered in colours other than red on a white or silver background, or white or silver on a red background.;It is a condition of registration that, in use, the cross device contained within the trade mark will be rendered in colours other than red on a white or silver background, or white or silver on a red background. It is a condition of registration that any use in respect of pharmaceuticals will be limited to such goods containing the substance designated by the International Non-Proprietary Name NALOXONE.

Endorsements

The mark consists of the words "Padagis" above "Naloxone and +.

It is a condition of protection that, in use, the cross device contained within the trade mark will be rendered in colours other than red on a white or silver background, or white or silver on a red background.;It is a condition of registration that, in use, the cross device contained within the trade mark will be rendered in colours other than red on a white or silver background, or white or silver on a red background.;It is a condition of registration that, in use, the cross device contained within the trade mark will be rendered in colours other than red on a white or silver background, or white or silver on a red background.

It is a condition of registration that any use in respect of pharmaceuticals will be limited to such goods containing the substance designated by the International Non-Proprietary Name NALOXONE.

Convention details
Date	06 May 2025
Number	383423
Country	ISRAEL

Indexing constituents

Word

PADAGIS

NALOXONE

Image

CHEVRON

DIVIDED

CROSS,GREEK

PLUS

SYMBOL,MATHEMATICAL

Australian Trade Mark Search

Trade mark 2597212

Goods & Services

Indexing constituents